Cerebral Inc., a fast-growing mental health and medication management startup based in San Francisco, recently announced it will stop prescribing most controlled substances to new patients starting this Friday....
The mental health care industry is rapidly evolving, with technology playing an increasingly vital role in making therapy more accessible and affordable. A prime...
Payer Relations Enter a New Era
As behavioral health reimbursement challenges and capacity shortages intensify across the U.S., Universal Health Services Inc. (NYSE: UHS) is...
San Francisco-based hybrid primary care provider One Medical (Nasdaq: ONEM) is expanding its hybrid primary care behavioral health offerings to attract more payer and...
The Biden Administration is driving forward an innovative approach to tackling the nation’s substance use crisis by promoting new reimbursement strategies for digital therapeutics...
On April 21, 2023, the Biden Administration unveiled a landmark plan to transform the federal government’s approach to substance use disorder (SUD). The National...